AGP
CNTA

Artia Global Partners’s Centessa Pharmaceuticals CNTA Stock Holding History

Artia Global Partners’s Portfolio CNTA Stock Details CNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-133,291
Closed -$3.23M – 59
2025
Q3 		$3.23M Buy
+133,291
New +$2.37M 0.51% 29
2025
Q2 		– Sell
-35,226
Closed -$507K – 39
2025
Q1 		$507K Sell
35,226
-45,154
-56% -$739K 0.13% 34
2024
Q4 		$1.35M Hold
80,380
– – 0.48% 31
2024
Q3 		$1.29M Buy
+80,380
New +$985K 0.35% 27

Other funds holding CNTA

MVM
Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Artia Global Partners's CNTA Position: Q4 2025 in Review

Artia Global Partners sold out of Centessa Pharmaceuticals (CNTA) in Q4 2025, closing a stake of 133,291 shares — an estimated $3.23M sold.

Artia Global Partners first reported a position in CNTA in Q3 2024 and held it in 4 quarters. The position peaked at $3.23M in Q3 2025. 146 funds tracked by Wall St. Rank hold CNTA as of Q4 2025.

  • Artia Global Partners reported no remaining Centessa Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Artia Global Partners sold 133,291 Centessa Pharmaceuticals shares in Q4 2025, an estimated $3.23M.
  • Artia Global Partners first reported a position in Centessa Pharmaceuticals in Q3 2024 and held it in 4 quarters.
  • Artia Global Partners's Centessa Pharmaceuticals position peaked at $3.23M in Q3 2025.
  • 146 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q4 2025.

Based on Artia Global Partners's 13F filing for Q4 2025, filed 17 Feb 2026.